Zhende Medical Co Ltd Working Capital to Net Assets Ratio
Zhende Medical Co Ltd working capital to net assets ratio. Zhende Medical Co Ltd (603301) has a Working Capital to Net Assets ratio of 19.4% as of June 2026. Working capital of CN¥1.15 Billion (current assets of CN¥2.90 Billion minus current liabilities of CN¥1.75 Billion) is measured against net assets of CN¥5.94 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Zhende Medical Co Ltd (2014–2025)
Working capital to net assets ratio of Zhende Medical Co Ltd from 2014 to 2025. This chart shows how Zhende Medical Co Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 19.4%, reflecting working capital of CN¥1.15 Billion against net assets of CN¥5.94 Billion CNY. See Zhende Medical Co Ltd (603301) defensive interval to measure how many days the company can operate on defensive assets alone.
Zhende Medical Co Ltd Working Capital to Net Assets Ratio by Year (2014–2025)
Zhende Medical Co Ltd working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Zhende Medical Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 603301 total asset value.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 17.6% | CN¥1.05 Billion | CN¥5.96 Billion | CN¥2.86 Billion | CN¥1.81 Billion | ▼ -7.6 pp |
| 2024 | 25.3% | CN¥1.49 Billion | CN¥5.90 Billion | CN¥2.65 Billion | CN¥1.16 Billion | ▼ -2.3 pp |
| 2023 | 27.6% | CN¥1.55 Billion | CN¥5.60 Billion | CN¥2.72 Billion | CN¥1.17 Billion | ▼ -17.8 pp |
| 2022 | 45.4% | CN¥2.62 Billion | CN¥5.76 Billion | CN¥4.13 Billion | CN¥1.52 Billion | ▲ +9.5 pp |
| 2021 | 35.9% | CN¥1.59 Billion | CN¥4.44 Billion | CN¥3.20 Billion | CN¥1.60 Billion | ▼ -22.7 pp |
| 2020 | 58.5% | CN¥2.62 Billion | CN¥4.47 Billion | CN¥4.35 Billion | CN¥1.74 Billion | ▲ +1.7 pp |
| 2019 | 56.9% | CN¥796.19 Million | CN¥1.40 Billion | CN¥1.59 Billion | CN¥798.31 Million | ▲ +25.5 pp |
| 2018 | 31.4% | CN¥352.63 Million | CN¥1.12 Billion | CN¥1.03 Billion | CN¥679.70 Million | ▲ +46.9 pp |
| 2017 | -15.5% | CN¥-87.04 Million | CN¥560.19 Million | CN¥576.08 Million | CN¥663.11 Million | ▲ +10.5 pp |
| 2016 | -26.1% | CN¥-114.28 Million | CN¥438.18 Million | CN¥494.60 Million | CN¥608.88 Million | ▲ +69.5 pp |
| 2015 | -95.5% | CN¥-250.73 Million | CN¥262.45 Million | CN¥745.93 Million | CN¥996.66 Million | ▲ +255.3 pp |
| 2014 | -350.8% | CN¥-371.07 Million | CN¥105.77 Million | CN¥576.79 Million | CN¥947.86 Million | — |